home ver. 2.3. site index contact us

Message from the CEO
How We Work
Business Integrity
History of Schering-Plough
Management Team
Schering-Plough Worldwide
Speeches & Presentations
The Schering-Plough Foundation
Diversity & Inclusion
Supplier Registration
Diversity Colleague Demographics

Management Biographies

KARL D. SALNOSKE
Vice President and Chief Information Officer
Schering-Plough Corporation
Kenilworth, New Jersey

Karl D. Salnoske is vice president and chief information officer of Schering-Plough Corporation.

Salnoske is responsible for directing the planning, acquisition, development and operation of computer, telecommunication and information systems for all corporate and divisional offices. He is also responsible for establishing the technical infrastructure and setting strategic guidelines for use of information systems technology throughout the company.

Salnoske joined the company in November 2004 from Adaptive Trade, where he was president and chief executive officer. Prior to this position, he served as general manager, software solutions, and as vice president, global services, at IBM. Throughout his career, Salnoske has held leadership positions with increasing responsibility at McKinsey & Co., Telenet, Xerox and Exxon.

Salnoske holds a B.S. degree in electrical engineering from Virginia Polytechnic Institute in Blacksburg, Va., where he serves on the advisory board for the Department of Electrical and Computer Engineering.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

 



Spotlight On

Combination Brochure

Brochure on the Combination

Basic Facts and Figures
•  World Headquarters:
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530
•  Chairman and CEO:
Fred Hassan
Number of employees:
55,000
Net sales (2007):
$12.7 billion
Business operations in more than:
140 countries
Largest-selling products:
VYTORIN*, ZETIA*, REMICADE, NASONEX.
R&D investment (2007):
$2.9 billion
Areas of research:
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $5.2 billion in 2007.
 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough